| scholarly article | Q13442814 |
| P356 | DOI | 10.1371/JOURNAL.PPAT.1006628 |
| P8608 | Fatcat ID | release_zuxc7yzdrfa5vkoidmjvo3l7hq |
| P932 | PMC publication ID | 5619862 |
| P698 | PubMed publication ID | 28922425 |
| P50 | author | David A Davis | Q89013829 |
| Coralie Viollet | Q89013831 | ||
| Robert Yarchoan | Q89013834 | ||
| P V Ravindra | Q58364310 | ||
| P2093 | author name string | Prabha Shrestha | |
| Robert F Carey | |||
| P2860 | cites work | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis | Q22009936 |
| Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells | Q24314526 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer | Q24630894 | ||
| Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. | Q24651016 | ||
| MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2 | Q24655427 | ||
| Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway | Q24672316 | ||
| A microRNA signature of hypoxia | Q24681599 | ||
| KSHV: pathways to tumorigenesis and persistent infection | Q27026000 | ||
| Allosteric inhibition of hypoxia inducible factor-2 with small molecules | Q27676596 | ||
| Targeting HIF-1 for cancer therapy | Q27860504 | ||
| Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases | Q28139317 | ||
| The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages | Q28143066 | ||
| Loss of PTEN facilitates HIF-1-mediated gene expression | Q28145476 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells | Q28245500 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| Proteomic screening of human targets of viral microRNAs reveals functions associated with immune evasion and angiogenesis | Q28536884 | ||
| Different Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma Cells | Q28547526 | ||
| Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics | Q29617786 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease | Q29619158 | ||
| Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation | Q29619687 | ||
| Activation of p90 ribosomal S6 kinase by ORF45 of Kaposi's sarcoma-associated herpesvirus and its role in viral lytic replication | Q30441657 | ||
| EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors | Q33261811 | ||
| Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells | Q33934809 | ||
| HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression | Q33968465 | ||
| Identification of properties of the Kaposi's sarcoma-associated herpesvirus latent origin of replication that are essential for the efficient establishment and maintenance of intact plasmids | Q34057984 | ||
| Distinct microRNA expression signatures are associated with melanoma subtypes and are regulated by HIF1A. | Q34115628 | ||
| An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease | Q34157797 | ||
| Kaposi's sarcoma herpesvirus microRNAs induce metabolic transformation of infected cells | Q34257830 | ||
| Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster | Q34717873 | ||
| hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer | Q34757861 | ||
| MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. | Q34995499 | ||
| Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia | Q35019982 | ||
| Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors | Q35139228 | ||
| Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors | Q35665756 | ||
| Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations | Q35693266 | ||
| Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production | Q35748754 | ||
| An Oncogenic Virus Promotes Cell Survival and Cellular Transformation by Suppressing Glycolysis | Q36019773 | ||
| Dysregulation of fatty acid synthesis and glycolysis in non-Hodgkin lymphoma | Q36122839 | ||
| RNA Sequencing Reveals that Kaposi Sarcoma-Associated Herpesvirus Infection Mimics Hypoxia Gene Expression Signature. | Q36238539 | ||
| KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma | Q36318661 | ||
| Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays | Q36731706 | ||
| Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells | Q36845797 | ||
| Identification of approved and investigational drugs that inhibit hypoxia-inducible factor-1 signaling | Q36946745 | ||
| Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice | Q37195150 | ||
| Hypoxic regulation of glutamine metabolism through HIF1 and SIAH2 supports lipid synthesis that is necessary for tumor growth | Q37576769 | ||
| MiRNA-210 modulates a nickel-induced cellular energy metabolism shift by repressing the iron-sulfur cluster assembly proteins ISCU1/2 in Neuro-2a cells | Q37620716 | ||
| Oxygen-independent regulation of HIF-1: novel involvement of PI3K/AKT/mTOR pathway in cancer | Q38072462 | ||
| AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV. | Q38073761 | ||
| Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis | Q38597909 | ||
| The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells | Q39698307 | ||
| EBV is necessary for proliferation of dually infected primary effusion lymphoma cells | Q39945651 | ||
| Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression | Q40002571 | ||
| Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha | Q40024042 | ||
| Hypoxia enhances the phosphorylation and cytotoxicity of ganciclovir and zidovudine in Kaposi's sarcoma-associated herpesvirus infected cells | Q40105402 | ||
| A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia | Q40106826 | ||
| Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression | Q40537413 | ||
| Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha. | Q40577584 | ||
| The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway | Q40594961 | ||
| Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus | Q40807418 | ||
| Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions | Q42049779 | ||
| The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha | Q42796220 | ||
| Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1 | Q44427386 | ||
| Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. | Q44633978 | ||
| Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells | Q44761629 | ||
| Prognostic Factors and Outcome of Human Herpesvirus 8–Associated Primary Effusion Lymphoma in Patients With AIDS | Q58416094 | ||
| Metabolism of neoplastic tissue. IV. A study of lipid synthesis in neoplastic tissue slices in vitro | Q73095194 | ||
| Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells | Q74541466 | ||
| Pleural effusions and hypoxemia | Q77311379 | ||
| Hypoxia-inducible factor 1 inhibitors | Q81589359 | ||
| P275 | copyright license | Creative Commons CC0 License | Q6938433 |
| P6216 | copyright status | copyrighted, dedicated to the public domain by copyright holder | Q88088423 |
| P433 | issue | 9 | |
| P304 | page(s) | e1006628 | |
| P577 | publication date | 2017-09-18 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Hypoxia-inducible factor-1 alpha as a therapeutic target for primary effusion lymphoma | |
| P478 | volume | 13 |
| Q91757226 | A role of hypoxia-inducible factor 1 alpha in Murine Gammaherpesvirus 68 (MHV68) lytic replication and reactivation from latency |
| Q93015526 | Effects of Hyperbaric Oxygen on T helper 17/regulatory T Polarization in Antigen and Collagen-induced Arthritis: Hypoxia-inducible Factor-1α as a Target |
| Q93074235 | KSHV-encoded LANA protects the cellular replication machinery from hypoxia induced degradation |
| Q89978541 | Production of Milk Phospholipid-Enriched Dairy Ingredients |
| Q92221509 | Remission of an HHV8-related extracavitary primary effusion lymphoma in an HIV-positive patient during antiretroviral treatment containing dolutegravir |
| Q91871600 | Sustain, Adapt, and Overcome-Hypoxia Associated Changes in the Progression of Lymphatic Neoplasia |
| Q92689673 | The Kaposi's Sarcoma-Associated Herpesvirus ORF34 Protein Interacts and Stabilizes HIF-2α via Binding to the HIF-2α bHLH and PAS Domains |
| Q92156491 | The Zebrafish Xenograft Platform-A Novel Tool for Modeling KSHV-Associated Diseases |
Search more.